FDA approves AI that detects collapsed lungs in chest X-rays

A new artificial intelligence-powered technology that alerts a medical team upon detecting signs of a collapsed lung in chest X-rays has received FDA clearance, Israeli imaging analytics company Zebra Medical Vision announced on May 13.

Advertisement

HealthPNX reads chest X-rays and digital radiography scans to find pneumothorax, which is among the most difficult conditions to interpret from imaging data, saving physicians more than 80 percent of the time it usually takes to detect the condition. The system then sends an urgent alert to healthcare providers and flags the scan in Zebra-Med’s other integrated radiology solutions.

The deep learning technology was trained to identify more than 40 common clinical findings from imaging data using millions of images. A subsequent study found that, on average, trained radiologists agreed with the findings of the HealthPNX algorithm more often than they agreed with each other’s assessments.

More articles about AI:
Machine learning can predict sudden death in patients with heart failure
LogitBoost algorithm predicts heart attacks, death with superhuman accuracy
AI can prevent hours of unnecessary testing for stable chest pain

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.